Detalhe da pesquisa
1.
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
Oncoimmunology
; 12(1): 2253644, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37720688